Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
American Journal of Physiology. Cell Physiology|May 15, 2001
Calpain 3 mRNA expression in mice after denervation and during muscle regenerationD Stockholm, M Herasse, S Marchand, et al.Cell|April 7, 1995
Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2AI Richard, O Broux, V Allamand, et al.Genomics|October 1, 1994
Regional localization of human chromosome 15 lociI Richard, O Broux, N Chiannilkulchai, et al.Gene Therapy|March 3, 2007
AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiencyM Bartoli, J Poupiot, A Vulin, et al.Human Molecular Genetics|February 1, 1994
Mapping of a chromosome 15 region involved in limb girdle muscular dystrophyF Fougerousse, O Broux, I Richard, et al.The Journal of Cell Biology|January 3, 2001
Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in miceI Richard, C Roudaut, S Marchand, et al.Brain : a Journal of Neurology|October 8, 1998
Limb-girdle muscular dystrophy in Guipúzcoa (Basque Country, Spain)M Urtasun, A Sáenz, C Roudaut, et al.Muscle & Nerve|October 15, 1998
Clinical, pathological, and genetic features of limb-girdle muscular dystrophy type 2A with new calpain 3 gene mutations in seven patients from three Japanese familiesH Kawai, M Akaike, M Kunishige, et al.Annals of Neurology|August 1, 1997
A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in TurkeyP Dinçer, F Leturcq, I Richard, et al.American Journal of Human Genetics|May 1, 1997
Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical originsI Richard, L Brenguier, P Dinçer, et al.Pageof 2